Clinical pharmacology of daunorubicin
Benjamin, R.S.
Cancer Treatment Reports 65(Suppl 4): 109-110
1981
ISSN/ISBN: 0361-5960 PMID: 6955010 Document Number: 175019
Document emailed within 1 workday
Related Documents
Wiernik, P.H.; Schimpff, S.C.; Schiffer, C.A.; Lichtenfeld, J.L.; Aisner, J.; O'connell, M.J.; Fortner, C. 1976: Randomized clinical comparison of daunorubicin (NSC-82151) alone with a combination of daunorubicin, cytosine arabinoside (NSC-63878), 6-thioguanine (NSC-752), and pyrimethamine (NSC-3061) for the treatment of acute nonlymphocytic leukemia Cancer Treatment Reports 60(1): 41-53Vyas, B. 2001: European Association of Clinical Pharmacology and Therapeutics--Fifth Congress. Clinical pharmacology: from molecule to society--bridging the gap via Man IDrugs: the investigational drugs journal 4(10): 1133-1137
Poulsen, H.Enghusen.; Schmitz, O.E.; Brøsen, K. 2002: Clinical pharmacology 2001--important events. The Danish Society of Clinical Pharmacology Ugeskrift for laeger 164(12): 1652
Duchêne-Marullaz, P. 1977: Pharmacology, clinical pharmacology and therapeutic effects of Royat's thermal gas Semaine des Hopitaux. Therapeutique 53(7-8): 361-362
Speth, P.A.; Minderman, H.; Haanen, C. 1989: Idarubicin v daunorubicin: preclinical and clinical pharmacokinetic studies Seminars in Oncology 16(1 Suppl 2: 2-9
Muggia, F.M.; Blum, R.H.; Wernz, J.C. 1981: Future clinical investigations with anthracycline antibiotics in relation to daunorubicin Cancer Treatment Reports 65(Suppl 4): 35-37
Daniele, B.; De Vivo, R.; Perrone, F.; Lastoria, S.; Tambaro, R.; Izzo, F.; Fiore, F.; Vallone, P.; Pignata, S. 2000: Phase i clinical trial of liposomal daunorubicin in hepatocellular carcinoma complicating liver cirrhosis Anticancer Research 20(2b): 1249-1251
Demchenko, V.T.; Kantariia, V.A.; Kerimov, B.L.; Shogentsukova, E.A.; Shomakhova, N.S. 1984: Clinical pharmacology and clinical pharmacy in a general clinical hospital Sovetskoe Zdravookhranenie 9: 27-29
Moiseev, V.S.; Lepakhin, V.K. 1989: Clinical pharmacology and problems of drug therapy in the clinical picture of internal diseases Terapevticheskii Arkhiv 61(8): 6-10
Simić, D.; Vrhovac, B. 1978: Clinical pharmacology: its importance, place, and role in larger clinical centers Medicinski Pregled 31(9-10): 403-408
Mandelli, F.; Petti, M.C.; Ardia, A.; Di Pietro, N.; Di Raimondo, F.; Ganzina, F.; Falconi, E.; Geraci, E.; Ladogana, S.; Latagliata, R. 1991: A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMA European Journal of Cancer 27(6): 750-755
Brandão, F.; Polónia, J. 1992: Clinical trials in cardiovascular clinical pharmacology Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(3): 273-281
Lunde, P.K. 1970: Clinical pharmacology Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 90(24): 2282-2284
Kshirsagar, N. 1991: Clinical pharmacology. Introduction Journal of the Association of Physicians of India 39(12): 941-942
Jaillon, P. 2002: The three pillars of clinical pharmacology Therapie 57(1): 3-5
Blackwell, J.; Newmark, S.R. 1984: Clinical pharmacology of glucocorticoids Journal of the Oklahoma State Medical Association 77(12): 422-426
Retterstol, N. 1973: Cannabis--clinical pharmacology Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(28): 2125-2126
Boda, D. 1987: Pediatric clinical pharmacology Orvosi Hetilap 128(45): 2375-2376
Kadyków, M. 1987: Clinical pharmacology of sulfadimethoxine Polski Tygodnik Lekarski 42(2): 47-50
Lowenthal, D.T. 1979: Clinical pharmacology of vasodilators New York State Journal of Medicine 79(1): 66-69